Skip to main content
Signal8
PALUMBO JOHN R profile photo

John R. Palumbo

CIK: 0001251475

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

DarioHealth Corp. logo
DRIO

DarioHealth Corp.

Director
Lucid Diagnostics Inc. logo
LUCD

Lucid Diagnostics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • DarioHealth Corp. logo
    DRIO

    DarioHealth Corp.

    Sep 24, 2026
    Award(A)
    Direct
    62K shares-
  • Lucid Diagnostics Inc. logo
    LUCD

    Lucid Diagnostics Inc.

    Feb 20, 2026
    Award(A)
    Direct
    123K shares-
  • Lucid Diagnostics Inc. logo
    LUCD

    Lucid Diagnostics Inc.

    Oct 6, 2025
    Award(A)

    Employee stock option (right to buy)

    Direct
    215K shares-

1-3 of 3

About PALUMBO JOHN R

PALUMBO JOHN R (SEC CIK 0001251475) files insider reports with the SEC as Director of DarioHealth Corp. (DRIO) and Director of Lucid Diagnostics Inc. (LUCD).

Signal8 holds 5 ownership filings by PALUMBO JOHN R (2 Form 3, 3 Form 4), filed between Oct 7, 2025 and Sep 28, 2026. Those filings report 3 transactions, from Oct 6, 2025 to Sep 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on PALUMBO JOHN R's filings is in NEW YORK, NY.

Recent filings by PALUMBO JOHN R

  • Sep 24, 2026: Grant or award of DRIO shares (Form 4, code A).
  • Feb 20, 2026: Grant or award of LUCD shares (Form 4, code A).
  • Oct 6, 2025: Grant or award of LUCD derivative securities (Form 4, code A).

Other insiders filing for DarioHealth Corp. (DRIO)

How to read Form 4 transaction codes